XTX Topco’s Amedisys AMED Stock Holding History

XTX Topco’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-32,225	Closed	-$3.17M	–	2520
2025 Q2	$3.17M	Buy	32,225 +23,242	+259%	+$2.2M	0.13%	174
2025 Q1	$832K	Sell	8,983 -12,714	-59%	-$1.17M	0.04%	671
2024 Q4	$1.97M	Buy	+21,697	New	+$1.99M	0.16%	87
2023 Q2	–	Sell	-4,894	Closed	-$360K	–	1384
2023 Q1	$360K	Buy	+4,894	New	+$423K	0.08%	509
2021 Q2	–	Sell	-1,973	Closed	-$522K	–	784
2021 Q1	$522K	Buy	+1,973	New	+$556K	0.25%	85

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

XTX Topco's AMED Position: Q3 2025 in Review

XTX Topco sold out of Amedisys (AMED) in Q3 2025, closing a stake of 32,225 shares — an estimated $3.17M sold.

XTX Topco first reported a position in AMED in Q1 2021 and held it in 5 quarters. The position peaked at $3.17M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

XTX Topco reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
XTX Topco sold 32,225 Amedisys shares in Q3 2025, an estimated $3.17M.
XTX Topco first reported a position in Amedisys in Q1 2021 and held it in 5 quarters.
XTX Topco's Amedisys position peaked at $3.17M in Q2 2025.
4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on XTX Topco's 13F filing for Q3 2025, filed 14 Nov 2025.